Analyst Ratings For MediciNova (NASDAQ:MNOV) (NASDAQ:MNOV)
Today, B. Riley initiated coverage on MediciNova (NASDAQ:MNOV) (NASDAQ:MNOV) with a Buy with a price target of $22.00.
Some recent analyst ratings include
- 3/28/2018-B. Riley initiated coverage with a Buy rating.
- 4/18/2017-Credit Suisse Group initiated coverage with a Outperform rating.
Recent Insider Trading Activity For MediciNova (NASDAQ:MNOV) (NASDAQ:MNOV)
MediciNova (NASDAQ:MNOV) (NASDAQ:MNOV) has insider ownership of 15.20% and institutional ownership of 18.79%.
- On 8/21/2017 Yoshio Ishizaka, Director, bought 5,000 with an average share price of $5.17 per share and the total transaction amounting to $25,850.00.
- On 5/15/2017 Yutaka Kobayashi, Director, bought 1,000 with an average share price of $5.60 per share and the total transaction amounting to $5,600.00.
- On 5/12/2017 Yutaka Kobayashi, Director, bought 24,000 with an average share price of $5.62 per share and the total transaction amounting to $134,880.00.
- On 9/15/2016 Yutaka Kobayashi, Director, bought 11,800 with an average share price of $6.44 per share and the total transaction amounting to $75,992.00.
- On 9/9/2016 Yutaka Kobayashi, Director, bought 10,000 with an average share price of $6.67 per share and the total transaction amounting to $66,700.00.
- On 7/5/2016 Geoffrey Obrien, VP, sold 3,300 with an average share price of $8.00 per share and the total transaction amounting to $26,400.00.
- On 12/10/2014 Yutaka Kobayashi, Director, bought 12,000 with an average share price of $3.54 per share and the total transaction amounting to $42,480.00.
Recent Trading Activity for MediciNova (NASDAQ:MNOV) (NASDAQ:MNOV)
Shares of MediciNova (NASDAQ:MNOV) closed the previous trading session at 12.48 up +0.85 7.31% with 62436 shares trading hands.